Volume 7, Issue 1 (2-2025)
pbp 2025, 7(1): 19-33 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
DAWOUD A, Hussien S D, Abdalbagi M, Shayoub M E H. Development, Optimization, and evaluation of New herbal Antipsoriatic Emulgel. pbp 2025; 7 (1) :19-33
URL: http://pbp.medilam.ac.ir/article-1-265-en.html
URL: http://pbp.medilam.ac.ir/article-1-265-en.html
1- assistant professor , azzadawoudhussien@gmail.com
2- Department of Dermatology, Faculty of Medicine,Omdurman Islamic University,Sudan
3- Medicinal and Aromatic Plants & Traditional Medicine Research Institute, National Center of Research, Sudan
4- Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Sudan
2- Department of Dermatology, Faculty of Medicine,Omdurman Islamic University,Sudan
3- Medicinal and Aromatic Plants & Traditional Medicine Research Institute, National Center of Research, Sudan
4- Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Sudan
Abstract: (137 Views)
Objective: It is acknowledged that psoriasis is the most prevalent autoimmune condition brought on by the improper activation of the immune system.
the lack of possible cure and associated severe side effects in allopathic medicines have led to extensive research in natural products with antipsoriatic activity. Bearing in mind this, and based on previous studies conducted at the Medicinal and Aromatic Plant and Traditional Medicine Research Institute (MAPTMRI), in which the activity of the Aloe sinkatan plant was proven as an effective treatment for psoriasis, it was selected to formulate, optimize and evaluate a new emulgel from Aloe sinkatana plant extract used as an anti-psoriatic agent.
Method: The study included a multi-phase process that included the collecting and extraction of plants. Based on pre-formulation studies like solubility and compatibility studies, liquid paraffin, propylene glycol, Tween-20 and Span-20, alcohol, and DEMSO were selected for the forumaltion. The emulgels were designed, formulate and optimized using a 2³ factorial design. Spreadability and viscosity were considered dependent variables, while the quantities of emulsifying agent, gelling agent and, liquid paraffin were chosen as independent formulation variables. Physical appearance and physiochemical parameters like stability, pH, viscosity, spreadability, and percentage medication content were evaluated for the produced formulations.
Results: Regression analysis showed that all three independent variables significantly affected the response variables. The formulation was optimized using a response surface plot using Design Expert software 8.0.7.1. The R² values for the response's viscosity and spreadability were 0.9915 and 0.9761, respectively.
Conclusion: Aloe sinkatana extract was used as an active component in the formulation of the emulgel form. Formula F3 shows good physicochemical characteristics and a higher percent of drug content than other formulations; therefore, it was selected as an optimal formula.
the lack of possible cure and associated severe side effects in allopathic medicines have led to extensive research in natural products with antipsoriatic activity. Bearing in mind this, and based on previous studies conducted at the Medicinal and Aromatic Plant and Traditional Medicine Research Institute (MAPTMRI), in which the activity of the Aloe sinkatan plant was proven as an effective treatment for psoriasis, it was selected to formulate, optimize and evaluate a new emulgel from Aloe sinkatana plant extract used as an anti-psoriatic agent.
Method: The study included a multi-phase process that included the collecting and extraction of plants. Based on pre-formulation studies like solubility and compatibility studies, liquid paraffin, propylene glycol, Tween-20 and Span-20, alcohol, and DEMSO were selected for the forumaltion. The emulgels were designed, formulate and optimized using a 2³ factorial design. Spreadability and viscosity were considered dependent variables, while the quantities of emulsifying agent, gelling agent and, liquid paraffin were chosen as independent formulation variables. Physical appearance and physiochemical parameters like stability, pH, viscosity, spreadability, and percentage medication content were evaluated for the produced formulations.
Results: Regression analysis showed that all three independent variables significantly affected the response variables. The formulation was optimized using a response surface plot using Design Expert software 8.0.7.1. The R² values for the response's viscosity and spreadability were 0.9915 and 0.9761, respectively.
Conclusion: Aloe sinkatana extract was used as an active component in the formulation of the emulgel form. Formula F3 shows good physicochemical characteristics and a higher percent of drug content than other formulations; therefore, it was selected as an optimal formula.
Keywords: Aloe sinkatana, anti-psoriatic properties, optimized formula, emulgel formulation, factorial analysis
Type of Study: Research |
Subject:
Herbal Drugs
Received: 2024/11/24 | Accepted: 2024/12/14 | Published: 2024/12/21
Received: 2024/11/24 | Accepted: 2024/12/14 | Published: 2024/12/21
References
1. Prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005 Jan;52(1):23-6. https://doi.org/10.1016/j.jaad.2004.07.045. PMID: 15627076.
2. The burden of psoriasis: a call for awareness. EClinicalMedicine. 2021;38:101114. https://doi.org/10.1016/j.eclinm.2021.101114.
3. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004 Jul;151(1):3-15. https://doi.org/10.1111/j.1365-2133.2004.06009.x. PMID: 15270867.
4. Berekmeri A, Mahmood F, Wittmann M, Helliwell P. Tofacitinib for the treatment of psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2018;14(9):719-30. https://doi.org/10.1080/1744666X.2018.1512404.
5. Hussien, Azza Dawoud. "Formulation and Evaluation of Aloe Sinkatana Gel as Anti-psoriatic Agent." PhD diss., University of Khartoum, Sudan, 2021.
6. Elhassan GOM, Adhikari A, Yousuf S, Rahman MH, Khalid A, Omer H, Fun HK, Jahan H, Choudhary MI, Yagi S. Phytochemistry and antiglycation activity of Aloe sinkatana Reynolds. J Phytochem Lett. 2012;725-728. https://doi.org/10.1016/j.phytol.2012.07.012.
7. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of Aloe Andongensis Extract, Aloe Andongensis Leaf Juice, Aloe Arborescens Leaf Extract, Aloe Arborescens Leaf Juice, Aloe Arborescens Leaf Protoplasts, Aloe Barbadensis Flower Extract, Aloe Barbadensis Leaf, Aloe Barbadensis Leaf Extract, Aloe Barbadensis Leaf Juice, Aloe Barbadensis Leaf Polysaccharides, Aloe Barbadensis Leaf Water, Aloe Ferox Leaf Extract, Aloe Ferox Leaf Juice, and Aloe Ferox Leaf Juice Extract. Int J Toxicol. 2007;26 Suppl 2:1-50. https://doi.org/10.1080/10915810701351186. PMID: 17613130.
8. Popadic D, et al. Aloe-emodin inhibits proliferation of adult human keratinocytes in vitro. J Cosmet Sci. 2012;63(5):297-302.
9. Pandey A, Srivastava N, Dubey RC, Dhaneshwar S, Shukla AK. Anti-psoriatic evaluation of aloe emodin-loaded topical hydrogel in an imiquimod-induced human plaque-type psoriasis in BALB/c mice. J Appl Pharm Sci. 2024 Sep;14(9):279-291. https://doi.org/10.7324/JAPS.2024.199942.
10. Mulye SP, Wadkar KA, Kondawar MS. Formulation development and evaluation of indomethacin emulgel. Der Pharmacia Sinica. 2013;4:31-45. https://doi.org/10.57239/PJLSS-2024-22.1.00335.
11. Asheer H, Krishnakumar K, Dinesh KB. Emulgel formulation: A novel approach for topical drug delivery system. Int J Pharm Sci Res. 2016;5:227-230.
12. Caddeo C, Sales OD, Valenti D, Saurí AR, Fadda AM, Manconi M. Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes, and PEVs. Int J Pharmaceutics. 2013;443(1-2):128-136. https://doi.org/10.1016/j.ijpharm.2012.12.041.
13. Panwar AS, Upadhyay N, Bairagi M, Gujar S, Darwhekar GN, Jain DK. Emulgel: A review. Asian J Pharm Life Sci. 2011;1(3):333-343.
14. Valecha SG, Dongaonkar CC, Dhole SN. Formulation and evaluation of herbal emulgel: A review article. Asian J Pharm Technol. 2023;13(4):297-303. https://doi.org/10.52711/2231-5713.2023.00053.
15. Singla V, Saini S, Joshi B, Rana AC. Emulgel: A new platform for topical drug delivery. Int J Pharm Biol Sci. 2012;3:485-498.
16. Reena K, Mittal S, Faizan M, et al. Enhancement of curcumin's anti-psoriatic efficacy via formulation into tea tree oil-based emulgel. Gels. 2023;9(12):973. https://doi.org/10.3390/gels9120973.
17. Hijazi A, Bandar H, Rammal H, Hachem A, Saad Z, Badran B. Techniques for the extraction of bioactive compounds from Lebanese urtica dioica. Am J Phytomed Clin Ther. 2013;1(6):507-513.
18. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20(1):63-67.
19. Yılmaz G, Tanrıverdi Tuncay S, Aksu B, Yeğen G, Özer O. Preparation and in vitro characterization of etofenamate emulgels using quality by design. J Res Pharm. 2019;23(6):1033-1039.
20. Ambala R, Vemula SK. Formulation and characterization of ketoprofen emulgels. J Appl Pharm Sci. 2015;5:112-117.
21. Jain BD, Padsalg A, Patel K, Mokale V. Formulation, development, and evaluation of fluconazole gel in various polymer bases. Asian J Pharm. 2007;1:63-68.
22. Plumb AP, Rowe RC, York P, Brown M. Optimisation of the predictive ability of artificial neural network (ANN) models: A comparison of three ANN programs and four classes of training algorithm. Eur J Pharm Sci. 2005;25(4-5):395-405.
23. Vasiljevic D, Parojcic J, Primorac M, Vuleta G. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier. Int J Pharmaceutics. 2006;309(1-2):171-177. https://doi.org/10.1016/j.ijpharm.2005.11.034.
24. Kamble A, Adnaik R, Bhutkar M. Formulation and evaluation of itraconazole emulgel for topical drug delivery. Int J Universal Pharm Bio Sci. 2014;3:37-45.
25. Mohite S, Salunkhe A. Formulation and evaluation of emulgel containing Coriandrum sativum seeds oil for anti-inflammatory activity. J Drug Deliv Ther. 2019;9(3-s):124-130.
26. Burki IK, Khan MK, Khan BA, Uzair B, Braga VA, Jamil QA. Formulation development, characterization, and evaluation of a novel dexibuprofen-capsaicin skin emulgel with improved in vivo anti-inflammatory and analgesic effects. AAPS PharmSciTech. 2020;21(6).
27. Yapar EA, İnal Ö, Erdal MS. Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil. Acta Pharmaceutica. 2013;63(4):531-543.
28. Kola-Mustapha AT, Taiwo SO, Isiaka AR, Amao SO, Ishola IO, Ghazali YO, Usman SO. Evaluation of Terminalia macroptera stem bark extract incorporated into an emulgel for the potential management of rheumatoid arthritis. Sci Afr. 2023;19:e01557.
29. Shelke O, Kulkarni A. Formulation, development and evaluation of nifedipine emulgel for treatment of anal fissures using polymeric emulsifiers. Indian J Pharm Educ Res. 2019;53(2):74-81.
30. Goyal S. Novel anti-inflammatory topical herbal gels containing Withania somnifera and Boswellia serrata. Int J Pharm Biol Arch. 2011;2:1087-1094.
31. Srilal TL, Hettihewa SK. Development and evaluation of a novel herbal emulgel for potential anti-inflammatory and antioxidant activities in vitro. CINEC Acad J. 2021;5(1):46-53.
32. Ashara KC, Paun JS, Soniwala M, Chavada JR, Mori NM. Micro-emulsion based emulgel: A novel topical drug delivery system. Asian Pac J Trop Dis. 2014;4:27-32.
33. Coneac G, Vlaia V, Olariu I, Muț AM, Anghel DF, Ilie C, Popoiu C, Lupuleasa D, Vlaia L. Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. AAPS PharmSciTech. 2015;16(4):889-904. https://doi.org/10.1208/s12249-014-0275-8.
34. Singh S, Parhi R, Garg A. Formulation of topical bioadhesive gel of aceclofenac using 3-level factorial design. Iran J Pharm Res. 2011;10(3):435-445.
35. Bhanu PV, Shanmugam L, Lakshmi PK. Development and optimization of novel diclofenac emulgel for topical drug delivery. Pharm Global. 2011;9:1-4.
36. Ali SM, Yosipovitch G. Skin pH: From basic science to basic skin care. Acta Dermato-Venereologica. 2013;93(3):261-267.
37. Kaur LP, Guleri TK. Topical gel: A recent approach for novel drug delivery. Asian J Biomed Pharm Sci. 2013;3(17):1-5.
38. Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibac H, et al. Topical and transdermal drug products. Pharmacopeial Forum. 2009;35(3):750-764.
39. Nair A, Jacob S, Al-Dhubiab B, Attimarad M, Harsha S. Basic considerations in the dermatokinetics of topical formulations. Brazilian J Pharm Sci. 2013;49(3):423-434.
40. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. Wound healing dressings and drug delivery systems: A review. J Pharm Sci. 2008;97(8):2892-2923.
41. Yassin GE. Formulation and evaluation of optimized clotrimazole emulgel formulations. Br J Pharm Res. 2014;4:1014-1030.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |